60 Degrees Pharmaceuticals (SXTP) Other Working Capital Changes (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Other Working Capital Changes of -$13650.0 for Q1 2024, down 11.46% year-over-year from -$15416.0 in Q2 2023, and down 3.79% quarter-over-quarter from -$13151.0 in Q4 2023.
60 Degrees Pharmaceuticals (SXTP) Other Working Capital Changes (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Other Working Capital Changes for 3 consecutive years, with -$13650.0 the latest figure, recorded in Q1 2024.
- In Q1 2024, Other Working Capital Changes fell 11.46% year-over-year to -$13650.0; the TTM figure through Dec 2024 stood at -$13650.0 (up 72.85% YoY), while the FY2024 annual figure was -$13650.0, up 72.85% from the prior year.
- Other Working Capital Changes fell to -$13650.0 in Q1 2024 per SXTP's latest filing, from -$13151.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.5 million in Q3 2023 and bottomed at -$990208.0 in Q4 2023.
- Historically, Other Working Capital Changes has averaged $94347.3 across 5 years, with a median of $29859.0 in 2025.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes slipped 5.0% — and 2024, when it slipped 11.46%.
- 60 Degrees Pharmaceuticals' Other Working Capital Changes stood at -$12524.0 in 2022, then slipped by 5.01% to -$13151.0 in 2023, then fell by 3.79% to -$13650.0 in 2024.
- Business Quant data shows SXTP's Other Working Capital Changes at -$13650.0 in Q1 2024, -$13151.0 in Q4 2023, and -$12669.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | 60 Degrees Pharmaceuticals | 2.95 Mn | 1.92 Mn | 56,798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 742,717.00 |
| Mar 31, 2026 | 742,717.00 |
| Mar 31, 2026 | 742,717.00 |
| Dec 31, 2025 | 29,859.00 |
| Dec 31, 2025 | 29,859.00 |
| Dec 31, 2025 | 29,859.00 |
| Sep 30, 2025 | 253,538.00 |
| Sep 30, 2025 | 253,538.00 |
| Sep 30, 2025 | 253,538.00 |
| Jun 30, 2025 | -132,222.00 |
| Jun 30, 2025 | -132,222.00 |
| Jun 30, 2025 | -132,222.00 |
| Mar 31, 2025 | -131,689.00 |
| Mar 31, 2025 | -131,689.00 |
| Mar 31, 2025 | -131,689.00 |
| Dec 31, 2024 | -60,333.00 |
| Dec 31, 2024 | -60,333.00 |
| Dec 31, 2024 | -60,333.00 |
| Sep 30, 2024 | 254,265.00 |
| Sep 30, 2024 | 254,265.00 |